Temasek Holdings to invest in Glenmark

Temasek Holdings is set to invest Rs 945 crore in Glenmark Pharmaceuticals through its wholly owned indirect subsidiary, Aranda Investments (Mauritius)


The company has decided to raise funds by way of issuance of up to 108,00,000 equity shares

Glenmark Pharmaceuticals has informed the Bombay stock exchange that Temasek Holdings, the investment arm of the Singapore government, is considering investing in the company through its wholly owned subsidiary Aranda Investments,  in equity shared to be issued by the company on a preferential basis. 

The company further said that it has decided to raise funds by way of issuance of upto 108,00,000 equity shares of Rs 1/- each on preferential basis for cash to Aranda, a foreign Portfolio investor, at a price of Rs 875 per equity share aggregating to Rs 945 crore, subject to requisite approvals of the shareholders and any regulatory authorities, as may be required.


Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box


GST: Boon or Bane for Healthcare?

Send this article by email